The Role of Positron Emission Tomography With 68Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy-Reference-Cited by-同舟云学术

The Role of Positron Emission Tomography With 68Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy

Published:2016-09 Issue: Volume:95 Page:11-15
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Rai Bhavan Prasad,Baum Richard Paul,Patel Amit,Hughes Robert,Alonzi Roberto,Lane Tim,Adshead Jim,Vasdev Nikhil

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013;Heidenreich;Eur Urol,2014

2. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?;Salami;BJU Int,2015

3. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis;Hovels;Clin Radiol,2008

4. The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis;Umbehr;Eur Urol,2013

5. Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy;Fuccio;Eur J Radiol,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep Learning-powered CT-less Multi-tracer Organ Segmentation from PET Images: A solution for unreliable CT segmentation in PET/CT Imaging;2024-08-28

2. Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate Cancer;Current Oncology;2023-11-08

3. PSA-Stratified Performance of [18F]DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer Patients under Androgen Deprivation Therapy;Diagnostics;2022-09-13

4. Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2021-09

5. The role of surgery in high risk and advanced prostate cancer: A narrative review;Türk Üroloji Dergisi/Turkish Journal of Urology;2021-02-08